Cyclerion Therapeutics Inc.
CYCN | NASDAQ
$23.52
$0.00 (0.00%)
Nov 2, 2026, 12:56 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.76M | -3.18M | -799K | -976K | -324K | -1.43M | 530K | -723K | -1.32M | -1.54M | -1.69M | 7.57M | -1.8M | -6.95M | -4.32M | -10.5M | -13.39M | -12.98M | -10.78M | -11.29M | -16.18M | -13.4M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.25K | 16.25K | 16.25K | 16.25K | n/a | n/a | 17K | 48K | 48K | 48K | 118K | 258K |
Stock-Based Compensation | 109K | n/a | n/a | 118K | 114K | 114K | 122K | 138K | 184K | 181K | 103K | 159K | n/a | 426K | n/a | 1.66M | 1.7M | 1.77M | 2.55M | n/a | n/a | 2.31M |
Other Working Capital | -868K | 994K | -3K | 151K | -328K | 279K | 134K | -740K | 123K | -54K | -335K | -1.16M | -788K | -641K | -2.41M | 41K | 606K | -2.24M | 2.4M | 1.28M | 709K | -3.4M |
Other Non-Cash Items | -58K | 58K | 95K | n/a | n/a | n/a | n/a | -363K | n/a | n/a | -16.25K | -12.46M | -2.02M | -16.25K | -1.77M | n/a | n/a | n/a | -3.56M | 2.41M | 9.55M | -12K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 272K | 1.94M | -875K | 594K | -293K | 347K | -292K | -768K | 32K | -510K | 50K | -2.21M | -2.75M | 314K | -951K | -1.08M | 854K | -1.67M | 3.11M | 908K | 1M | -3.61M |
Operating Cash Flow | -1.43M | -1.18M | -1.58M | -264K | -503K | -968K | 360K | -1.72M | -1.11M | -1.87M | -1.54M | -6.94M | -6.56M | -6.21M | -7.04M | -9.92M | -10.82M | -12.84M | -8.63M | -7.92M | -5.51M | -14.46M |
Capital Expenditures | 66K | -66K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 1.46M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -66K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7K | 2K | 1.46M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6K | 30.5M | n/a |
Financial Cash Flow | n/a | 825K | 251K | 1.83M | -130K | 1.38M | n/a | n/a | n/a | n/a | n/a | n/a | 5.02M | n/a | 12K | n/a | 17K | n/a | 85K | 43K | 30.63M | 27K |
Net Cash Flow | -1.43M | -417K | -1.33M | 1.56M | -633K | 407K | 360K | -1.72M | -1.11M | -1.88M | -1.54M | 3.47M | -1.53M | -6.21M | -7.02M | -9.92M | -10.8M | -12.84M | -8.54M | -7.89M | 28.96M | -12.97M |
Free Cash Flow | -1.37M | -1.24M | -1.58M | -264K | -503K | -968K | 360K | -1.72M | -1.11M | -1.87M | -1.54M | -6.94M | -6.56M | -6.21M | -7.04M | -9.92M | -10.82M | -12.84M | -8.63M | -7.93M | -5.51M | -14.46M |
Adj. Free Cash Flow | -1.48M | -1.24M | -1.58M | -382K | -617K | -1.08M | 238K | -1.85M | -1.29M | -2.05M | -1.64M | -7.09M | -6.56M | -6.64M | -7.04M | -11.58M | -12.52M | -14.6M | -11.18M | -7.93M | -5.51M | -16.77M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7K | n/a | n/a |
Growth CapEx | 66K | -66K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -1.43M | -1.18M | -1.58M | -264K | -503K | -968K | 360K | -1.72M | -1.11M | -1.87M | -1.54M | -6.94M | -6.56M | -6.21M | -7.04M | -9.92M | -10.82M | -12.84M | -8.63M | -7.93M | -5.51M | -14.46M |
Add to Watchlist
Select watchlists to add or remove CYCN